| Patel, Ashish S |
CAMEO, NCT05781152: Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease |
|
|
| Recruiting | 4 | 900 | Canada, US | Anti-TNF therapy, Remicade, Inflectra, Renflexis, Avsola, Humira, Amgevita, Hulio, Hadlima, Hyrimoz, Idacio | Connecticut Children's Medical Center, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Emory University, Children's Hospital Medical Center, Cincinnati, University of North Carolina, Chapel Hill | Crohn Disease | 07/28 | 07/29 | | |
| Active, not recruiting | 3 | 417 | US | SB-01 For Injection, Sham Needle | Spine BioPharma, Inc, MCRA | Lumbar Degenerative Disc Disease | 02/25 | 08/25 | | |
| Recruiting | 3 | 120 | Europe, Canada, Japan, US, RoW | Vedolizumab IV, ENTYVIO, KYNTELES, MLN0002 | Takeda, Takeda Development Center Americas, Inc. | Crohn's Disease (CD) | 11/24 | 11/24 | | |
| Active, not recruiting | 3 | 121 | Europe, Canada, Japan, US, RoW | Vedolizumab, MLN0002, ENTYVIO, KYNTELES | Takeda, Takeda Development Center Americas, Inc. | Colitis, Ulcerative | 08/25 | 08/25 | | |
| Recruiting | 3 | 240 | Europe, Canada, Japan, US, RoW | Vedolizumab IV, MLN0002, ENTYVIO, KYNTELES, No Intervention | Takeda, Takeda Development Center Americas, Inc. | Ulcerative Colitis, Crohn's Disease | 08/31 | 08/31 | | |
OPAL, NCT03077841: Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer |
|
|
| Active, not recruiting | 2/3 | 928 | US | Laboratory Biomarker Analysis, Partial Breast Irradiation, Questionnaire Administration | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Ductal Breast Carcinoma In Situ, Early-Stage Breast Carcinoma, Invasive Breast Carcinoma, Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7 | 11/27 | 11/27 | | |
| Recruiting | 1/2 | 5 | Europe | MON002 | Guy's and St Thomas' NHS Foundation Trust, King's College London | Pulmonary Fibrosis, Interstitial Lung Disease, Covid19 | 06/22 | 03/23 | | |
PLEA, NCT04216667: Posterior Wall And Left Atrial Appendage Empiric Electrical Isolation for Non-Paroxysmal Atrial Fibrillation |
|
|
| Terminated | N/A | 124 | Europe, US, RoW | Catheter ablation | Montefiore Medical Center, Biosense Webster, Inc. | Atrial Fibrillation | 06/23 | 06/23 | | |
| Recruiting | N/A | 3000 | US | Treatment Recommendation Surveys, 7-gene biosignature | PreludeDx, University of South Florida | DCIS | 12/25 | 12/35 | | |
| Kenkel, Jeffrey M |
NCT05085730: Assessment Skin Quality and Efficacy of Dermal Line After Four Bipolar Radiofrequency Microneedling Treatments |
|
|
| Completed | N/A | 13 | US | InMode Morpheus8 System | University of Texas Southwestern Medical Center | Aging | 12/22 | 12/22 | | |
NCT04558840: Enhanced Recovery After Bilateral Reduction Mammaplasty |
|
|
| Terminated | N/A | 54 | US | Macromastia, Mammaplasty | University of Texas Southwestern Medical Center | Pain | 05/23 | 11/23 | | |
NCT05493280: Fractionated 1927nm Laser for Hyperpigmentation in Fitzpatrick Skin Phototypes V and VI |
|
|
| Completed | N/A | 20 | US | MOXI | University of Texas Southwestern Medical Center | Hyperpigmentation | 07/24 | 12/24 | | |
NCT05028816: Force Modulating Tissue Bridges for Closure of Vertical Scars in Breast Reduction |
|
|
| Active, not recruiting | N/A | 42 | US | Side 1: Final layer closure with force modulating tissue bridges (FMTB), Brijjit, Side 1: Final layer dermal closure with poliglecaprone 25 suture, Side 2: Final layer closure with force modulating tissue bridges (FMTB), Side 2: Final layer dermal closure with poliglecaprone 25 suture | University of Texas Southwestern Medical Center | Surgical Incision | 04/24 | 12/24 | | |
NCT04616898: Analysis of the Performance of 1060 nm Diode and Radio Frequency Prior to Abdominoplasty |
|
|
| Completed | N/A | 12 | US | Venus Bliss | Venus Concept, University of Texas | Adipose Tissue Atrophy | 11/23 | 11/23 | | |
NCT06317766: Histological Study of the Effects of a 2910 nm Fiber Laser Technology |
|
|
| Enrolling by invitation | N/A | 2 | US | 2910 nm Fiber Laser Treatment; Pre-Clinical Histology Evaluation, 2910 nm Fiber Laser Treatment; Part 2 Histology Evaluation | FA Corporation, University of Texas Southwestern Medical Center | Skin Laxity | 04/24 | 05/24 | | |
NCT06091215: Combining Broad Based Light (BBL), Fractionated 1927 (MOXI) and Dual Wavelength 2940/1470 (HALO) |
|
|
| Active, not recruiting | N/A | 15 | US | Sciton Joule System | University of Texas Southwestern Medical Center, Sciton | Pigment Skin | 06/24 | 12/24 | | |
| Assa, Shlomo |
NCT06317766: Histological Study of the Effects of a 2910 nm Fiber Laser Technology |
|
|
| Enrolling by invitation | N/A | 2 | US | 2910 nm Fiber Laser Treatment; Pre-Clinical Histology Evaluation, 2910 nm Fiber Laser Treatment; Part 2 Histology Evaluation | FA Corporation, University of Texas Southwestern Medical Center | Skin Laxity | 04/24 | 05/24 | | |
